Literature DB >> 22547188

Predictors of asymptomatic malaria in pregnancy.

S T Balogun1, O A Adeyanju, A A Adedeji, F A Fehintola.   

Abstract

A number of studies have described malaria parasitaemia in pregnancy as mostly an asymptomatic condition, however information about predictors of asymptomatic malaria is largely lacking. We investigated the prevalence of symptoms and potential predictors of asymptomatic malaria in pregnant women attending Ante-Natal Clinic (ANC) of two public maternity hospitals in Ibadan, Southwest-Nigeria. Demographic data, history of previous and present pregnancy were obtained from the subjects and blood smears were examined for malaria diagnosis by light microscopy. Seventy - seven parasitaemic pregnant women attending antenatal clinic were evaluated for presence or absence of symptoms that may be associated with malaria. Thirty-seven women (48%) were asymptomatic whereas 40 (52%) presented with symptoms such as weakness, headache and general body ache and fever. Parasite density was significantly higher in symptomatic patients (P = 0.042), while asymptomatic patients had low level parasitaemia but significantly higher gametocyte carriage (P = 0.035). In conclusion, parasitaemic pregnant women resident in hyper- or holo-endemic malaria region are likely to be symptomatic with increasing density of the parasitaemia.

Entities:  

Mesh:

Year:  2011        PMID: 22547188

Source DB:  PubMed          Journal:  Niger J Physiol Sci        ISSN: 0794-859X


  2 in total

1.  PREVALENCE OF MALARIA PARASITAEMIA AND THE USE OF MALARIA PREVENTION MEASURES IN PREGNANT WOMEN IN IBADAN, NIGERIA.

Authors:  F A Bello; A I Ayede
Journal:  Ann Ib Postgrad Med       Date:  2019-12

2.  Prevalence of asymptomatic Plasmodium species infection and associated factors among pregnant women attending antenatal care at Fendeka town health facilities, Jawi District, North west Ethiopia: A cross-sectional study.

Authors:  Adane Tilahun; Mulat Yimer; Woynshet Gelaye; Banchamlak Tegegne
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.